Highlights From AACR IO 2026: Breaching the Tumor Microenvironment Fortress With New CAR T and Chimeras
Three innovative studies at AACR IO 2026 presented new ways for CAR T cells and antibody-lectin chimeras to tackle...
Three innovative studies at AACR IO 2026 presented new ways for CAR T cells and antibody-lectin chimeras to tackle...
The AACR Annual Meeting 2023 kicks off Friday, April 14, with thousands of cancer researchers from around the world...
As we welcome spring, enjoy the latest round of editors’ picks selected by the editors of AACR’s 10 journals....
Outside the lab, Frank McCormick, PhD, FAACR, is a racecar driver, nurturing a passion he developed decades ago. (“We...
How the latest clinical therapies are helping patients and laboratory research informing future treatments.
The 2020 death of actor Chadwick Boseman shocked the public, sparking grief in those who revered his portrayal of...
The immune system is designed to operate like a well-oiled machine. With a myriad of distinct cell types, a...
As February gives way to March, we bring you the latest round of editors’ picks selected by the editors...
In the United States, about 40% of cancer cases are associated with preventable risk factors. According to the AACR...
Two years ago, amid increased awareness of the need to diversify the scientific work force and end cancer health...
Throughout his career as a cancer researcher, Robert A. Winn, MD, has seen a familiar pattern in progress. Each...